DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparison of double bolus urokinase versus front-loaded alteplase regimen for acute myocardial infarction. Thrombolysis in Myocardial Infarction in Korea (TIMIKO) study group.

Author(s): Park SJ

Affiliation(s): Department of Medicine, University of Ulsan, Asan Medical Center, Seoul, Korea.

Publication date & source: 1998-09-15, Am J Cardiol., 82(6):811-3, A10.

Publication type: Clinical Trial; Multicenter Study; Randomized Controlled Trial

This study was performed to compare the double bolus urokinase regimen with the front-loaded alteplase regimen for acute myocardial infarction. Double bolus urokinase is an easy, safe, and effective thrombolytic regimen with comparable results to standard front-loaded alteplase in acute myocardial infarction.

Page last updated: 2006-01-31

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009